Search clinical trials for: Growth Substances

Total 7148 results

Oregon State University
Oregon Health and Science University; National Center for Complementary and...

Completed

Xanthohumol and Metabolic Syndrome

Metabolic Syndrome

United States
Novartis Pharmaceuticals

Completed

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment (RELIGHT)

Diabetic Retinopathy | Macular Oedema

United Kingdom
Mie University

Unknown

Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO (CRVO)

Central Retinal Vein Occlusion

Japan
Sinocelltech Ltd.

Recruiting

This Study Will Compare the Efficacy and Safety of SCT510A Administered by Intravitreal Injection (IVT) With Ranibizumab in Patients With wAMD

Wet Age-related Macular Degeneration

China
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Recruiting

601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV)

Pathological Myopic Choroidal Neovascularization

China
University of California, San Francisco
Genentech, Inc.

Terminated

Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery

Glaucoma

United States
University of Colorado, Denver

Completed

Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma

Neovascular Glaucoma

United States
Poitiers University Hospital

Active, not recruiting

Real Life Study in Myopic Neovascularization (VIC)

Myopic Choroidal Neovascularisation

France
Justis Ehlers
Regeneron Pharmaceuticals

Completed

Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO (PERMEATE)

Central Retinal Vein Occlusion | Diabetic Macular Edema | Retinal Vein Occlusion | Branch Retinal Vein Occlusion

United States
Novartis Pharmaceuticals

Completed

Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications (PACIFIC)

Neovascular (Wet) Age-related Macular Degeneration

Germany, Switzerland, Netherlands
Amy C Schefler, MD
Regeneron Pharmaceuticals

Unknown

Intravitreal Aflibercept Injection for Radiation Retinopathy Trial (ARRT)

Radiation Retinopathy

United States
Second Military Medical University

Unknown

Anti-VEGF Intravitreous Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery (Anti-VEGF)

Diabetic Macular Edema | Cataract

China
Hospices Civils de Lyon

Completed

Study Evaluating the Efficacy of Aflibercept for the Treatment of NVCI in Young Patients (INTUITION)

Idiopathic Choroidal Neovascularization

France
Johannes Gutenberg University Mainz
Novartis

Completed

Functional and Structural Outcomes in Neovascular Age-related Macular Degeneration (CAPTAIN)

Neovascular Age-related Macular Degeneration

Germany
California Retina Consultants
Genentech, Inc.

Completed

Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab (REEF)

Diabetic Macular Edema

United States
Poitiers University Hospital

Completed

Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment

Diabetic Macular Edema

France
Philip J. ferrone, M.D.

Completed

Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema

Clinically Significant Diabetic Macular Edema

United States
University of California, San Diego
Genentech, Inc.

Withdrawn

Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Hereditary Hemorrhagic Telangiectasia (HHT) | Nosebleeds
University Health Network, Toronto

Completed

Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab Dosing

Age Related Macular Degeneration

Canada
Facet Biotech
Biogen

Terminated

A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer

Peritoneal Neoplasms | Ovarian Cancer

United States, Canada
University of Melbourne

Completed

Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration

Choroidal Neovascularization | Retinal Pigment Epithelial Detachment

Australia
Retina Institute of Hawaii

Completed

Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis

Wet AMD

United States
Shields, Shields and Associates

Unknown

Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy

Uveal Melanoma | Radiation Retinopathy | Radiation Maculopathy

United States
McMaster University
Hoffmann-La Roche

Recruiting

Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial (INSITE-DME)

Diabetic Macular Edema

Australia, United States, Canada, United Kingdom
University of Nebraska
Regeneron Pharmaceuticals

Completed

Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration (DRAW)

Neovascular Macular Degeneration

United States
University Hospital Inselspital, Berne

Completed

Comparison of Treatment rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen

Age Related Macular Degeneration

Switzerland
Xbrane Biopharma AB
Stada Arzneimittel AG

Completed

Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD (XPLORE)

Macular Degeneration

Israel, Spain, Hungary, United States, Slovakia, Lithuania, Bulgaria, Czechia, Estonia, India, Latvia, Poland, Romania, Russian Federation, Ukraine
Gangnam Severance Hospital
Novartis; Inje University; Severance Hospital; Konkuk University

Completed

Cytokeratin 8 Level in Age-related Macular Degeneration

Age-related Macular Degeneration

Korea, Republic of
Justis Ehlers
Genentech, Inc.

Completed

Safety and Efficacy of Ranibizumab for Diabetic Macular Edema (REACT)

Diabetic Macular Edema

United States
Nagoya City University
Novartis

Completed

Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion

Japan
Novartis Pharmaceuticals

Completed

Safety and Tolerability of Ranibizumab in Mono/Bilateral Wet Age Related Macular Degeneration (w-AMD) Patients in Eyes With BCVA<2/10 and/or 2nd Affected Eye (TWEYES)

Wet Age Related Macular Degeneration

Italy
Oregon Health and Science University
Genentech, Inc.

Completed

Lucentis (Ranibizumab) for Eales' Disease

Eales' Disease

United States
Ophthalmica Eye Institute

Unknown

Management of Patients With Neovascular Age-related Macular Degeneration Undergoing Cataract Surgery

Wet Macular Degeneration | Cataract Extraction

Greece
Shinshu University

Completed

Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula Edema

Diabetic Macula Edema

Japan
Federal University of São Paulo
Novartis

Withdrawn

Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular Edema

Diabetic Macular Edema

Brazil
Marsden Eye Specialists

Completed

To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes Mellitus (CONTROL)

Diabetic Macular Oedema

Australia
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Recurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Adenocarcinoma | Endometrial Adenosquamous Carcinoma | Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation | Endometrioid Stromal Sarcoma

United States
Vista Klinik

Completed

Time Course of Activity Signs at SD-OCT High Frequency Intravitreal Ranibizumab Treatment in CNV Due to AMD

Age Related Macular Degeneration | Choroidal Neovascularization

Switzerland
Instituto de Olhos de Goiania

Completed

Assessment of Color Vision in Diabetic Patients

Retinopathy, Diabetic

Brazil
Novartis Pharmaceuticals

Completed

Ranibizumab "Treat and Extend" in Diabetic Macular Edma (OPTIMAL)

Diabetic Macular Edema

Norway
David M. Brown, M.D.
Genentech, Inc.

Terminated

A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial) (SAVE)

Macular Degeneration | Age Related Macular Degeneration | Wet Age-Related Macular Degeneration | Choroidal Neovascular Membrane | Subfoveal Neovascular Age-Related Macular Degeneration

United States
University of Colorado, Denver
Genentech, Inc.

Completed

Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy (NAION)

Nonarteritic Anterior Ischemic Optic Neuropathy

United States
Ruijin Hospital
Ningbo University

Completed

Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma

Diabetic Retinopathy | Glaucoma, Neovascular
Valley Retina Institute

Unknown

Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioN (ELYSIAN)

Proliferative Diabetic Retinopathy
Retina Center, Minnesota
Genentech, Inc.

Completed

ERG/EOG Study in AMD Patients Treated With Ranibizumab (FVF4154s)

Age-Related Macular Degeneration

United States
John Kitchens, MD

Unknown

Treatment for Presumed Ocular Histoplasmosis (HANDLE)

Ocular Histoplasmosis

United States
California Retina Consultants
Genentech, Inc.

Completed

Lucentis for Central Retinal Vein Occlusion (CRVO)

Central Retinal Vein Occlusion

United States
Vision Research Foundation
Genentech, Inc.

Completed

Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy (PVD)

Choroidal Neovascularization

United States
Abbott
Biogen

Terminated

A Study of Volociximab in Metastatic Melanoma

Stage IV Melanoma

United States
University of California, Los Angeles

Withdrawn

Increlex Treatment of Children With Chronic Liver Disease and Short Stature

Growth Failure | Chronic Liver Disease

Search clinical trials for: Growth Substances

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations